EDWARDS LIFESCIENCES CORPORATION vs WEST PHARMACEUTICAL SERVICES, INC., two Medical Devices stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where EW and WST diverge most: on gross margin, EW reads 78.0% and WST reads 37.7%; on return on equity, EW reads 10.6% and WST reads 18.9%. The rest of the comparable metrics sit closer together. What EW's price implies is a bet that sits within the historical range (whole-company basis). What WST's price implies is a somewhat stretched bet versus history (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | EW | WST |
|---|---|---|
| Price | $86.03 | $341.01 |
| Market cap | $50.0B | $24.3B |
| Sector | Medical Devices | Medical Devices |
| Stage | Growth | Mature |
| P/E | 45.8 | 43.7 |
| P/B | 4.84 | 8.13 |
| P/S | 7.93 | 7.31 |
| EV/EBITDA | 34.7 | 27.9 |
| Revenue growth | +14.1% | +12.5% |
| Gross margin | 78.0% | 37.7% |
| Operating margin | 29.0% | 20.5% |
| Net margin | 17.4% | 17.0% |
| Return on equity | 10.6% | 18.9% |
| Return on assets | 8.2% | 13.9% |
| Return on invested capital | 10.2% | 17.5% |
| FCF yield | 2.2% | 1.8% |
| Dividend yield | — | 0.3% |
| Debt / equity | 0.06 | 0.07 |
| Current ratio | 4.42 | 2.82 |
| Altman Z (solvency) | 8.56 | 8.89 |
| Piotroski F (quality) | 5 / 9 | 6 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.